North America Human Microbiome Market Trends and Analysis by 2025
North America Human Microbiome Market to 2025 - Regional Analysis and Forecasts by Product (Probiotics, Foods, Prebiotics, Medical Foods, Diagnostic Device, Drugs, and Supplements), Disease (Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders, and Others), Application (Therapeutics and Diagnostics), and Country
- Report Date : Feb 2019
- Report Code : TIPRE00003319
- Category : Life Sciences
- Status : Published
- Available Report Formats :
- No. of Pages : 152
The North America human microbiome market is expected to reach US$ 446.39 Mn in 2025 from US$ 113.88 in 2017. The market is estimated to grow with a CAGR of 21.5% from 2018-2025.
The growth of the market is driven by the factors such as increasing incidence of lifestyle diseases, increasing focus on human microbiome therapies and growing technological advancements in human microbiome and next-generation sequencing. Whereas, strict government guidelines and lack of knowledge and detailed examination is likely to have a negative impact on the growth of the market in the coming years.
Humans are never alone as they coexist with the diverse microbial species that live within and upon humans. From recent studies it has been very clear that this microbial community is essentially another organ of the body that plays a crucial role in human physiology and disease. Several basic and translational research efforts have been initiated to focus on deciphering mechanisms of microbiome function and how it benefits the human health. Many human medical conditions (like inflammatory bowel diseases and obesity) have been closely associated with or are thought to be influenced by (asthma and diabetes) the composition of the gut microbial community. Many efforts are taken to alter the gut microbiome to eradicate several diseases. Probiotics, prebiotics dietary supplements and foods that contain live microbes have been studied thoroughly to assess their effects on human health.
The Human Microbiome Project of the National Institutes of Health in the United States and related international efforts are defining the varieties of a normal microbiome, studying how changes in the microbiota relate to disease. Large governmental research initiatives including the Human Microbiome Project in the U.S. have accelerated research on the human microbiome.
Also, many companies are designing and developing many microbiome therapies. For instance, Rebiotix Inc. has developed Microbiota Restoration Therapy (MRT) drug platform which is the drug platform for delivering healthy, live, human-derived microbes into a sick patient’s intestinal tract to treat disease. Thus, the increasing focus on human microbiome therapies is the prime factor driving the growth of human microbiome market in the coming years.
US is anticipated to lead the adoptions of Human microbiome across the North American region through the forecast period. The application of the human microbiome are beneficial for various treatment areas such as cancer, Inflammatory Bowel Disease (IBD), diabetes, autoimmune diseases and more. To be specific with the applications of the human microbiome, it plays important role in the developments in wide range of diseases and disorders which includes cardiovascular disease, cancer, autoimmune, neurological disorders and more. Therefore, various programs are being organized in the country to grow the awareness of probiotics and prebiotics in order to enhance the human microbiome.
For instance, in February 2018, the 3rd Annual North America Microbiome Congress was held in San Diego, by Kisaco Research that focused on 5 microbiome niches such as the gut, lung, oral, skin and vaginal and provided latest insights on microbiome research, clinical trials and collaborative partnerships.
Thus, owing to the above mentioned factors the market for the human microbiome is likely to grow with a significant growth rate in the coming forecast years.
Mexico Human microbiome Market Revenue and Forecasts to 2027 (US$ Bn)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
NORTH AMERICA HUMAN MICROBIOME- MARKET SEGMENTATION
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
By Product
• Probiotics
• Foods
• Prebiotics
• Medical Foods
• Diagnostic Device
• Drugs
• Supplements
NORTH AMERICA HUMAN MICROBIOME- MARKET SEGMENTATION
By Disease
• Obesity
• Diabetes
• Autoimmune Disorders
• Cancer
• Mental Disorders
• Others
NORTH AMERICA HUMAN MICROBIOME- MARKET SEGMENTATION
By Application
• Therapeutics
• Diagnostics
By Country
• U.S.
• Canada
• Mexico
Companies Mentioned
• Enterome
• MicroBiome Therapeutics, LLC
• Rebiotix Inc.
• Yakult Honsha Co., Ltd.
• Osel Inc.
• Vedanta Biosciences, Inc.
• Metabiomics Corporate
• Synthetic Biologics, Inc.
• DuPont
• BiomX Ltd.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product, Disease, Application, and Country
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
US, Canada
PART 1. iNTRODUCTION
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
PART 2. North America Human microbiome Market – Key takeaways
PART 3. North America Human microbiome market – market landscape
3.1 overview
3.2 market segmentation
3.2.1 North America Human Microbiome Market – By Product
3.2.2 North America Human Microbiome Market – By Disease
3.2.3 North America Human Microbiome Market – By Application
3.2.4 North America Human Microbiome Market – By Country
3.3 PEST Analysis
3.3.1 North America – PEST Analysis
PART 4. North America HUMAN MICROBIOME market- Key Market Dynamics
4.1 Key Market Drivers
4.1.1 Growing Prevalence of Chronic Diseases
4.1.2 Increasing Research and Development on Human Microbiome-Based Therapies
4.1.3 Rapid adoption of Metagenomics and Next-Generation Sequencing techniques
4.2 Key Market Restraints
4.2.1 Stringent Regulatory Framework
4.2.2 Lack of Expertise In Human Microbiome
4.3 Key Market Opportunities
4.3.1 Developing Fecal Microbiota Transplantation (FMT) Therapies
4.4 future Trends
4.4.1 Growing Human Microbiome Research in Drug Discovery
4.5 Impact analysis
PART 5. Human microbiome market – North America Analysis
5.1 North America Human microbiome market Revenue Forecasts and Analysis
5.2 Market positioning
5.3 PERFORMANCE OF KEY PLAYERS
Enterome
Yakult Honsha Co., Ltd.
5.4 expert opinions
PART 6. North America Human microbiome market Analysis – By Product
6.1 Overview
6.2 NORTH AMERICA Human microbiome MARKET, BY product, 2017 & 2025 (%)
6.3 North America Human microbiome market Revenue And Forecasts to 2025, By Product (US$ Mn)
6.4 FOODS Market
6.4.1 Overview
6.4.2 North America Foods Market Revenue and Forecasts to 2025 (US$ Mn)
6.5 Medical food Market
6.5.1 Overview
6.5.2 North America Medical Food Market Revenue and Forecasts to 2025 (US$ Mn)
6.6 probiotics Market
6.6.1 Overview
6.6.2 North America Probiotics Market Revenue and Forecasts to 2025 (US$ Mn)
6.7 prebiotics Market
6.7.1 Overview
6.7.2 North America Prebiotics Market Revenue and Forecasts to 2025 (US$ Mn)
6.8 drugs Market
6.8.1 Overview
6.8.2 North America Drugs Market Revenue and Forecasts to 2025 (US$ Mn)
6.9 DIAGNOSTIC DEVICES Market
6.9.1 Overview
6.9.2 North America Diagnostic Devices Market Revenue and Forecasts to 2025 (US$ Mn)
6.10 SUPPLEMENTS Market
6.10.1.Overview
6.10.2.North America Supplements Market Revenue and Forecasts to 2025 (US$ Mn)
PART 7. North America human microbiome market Analysis – By disease
7.1 Overview
7.2 NORTH AMERICA Human microbiome MARKET, BY disease, 2017 & 2025 (%)
7.3 North America Human microbiome market Revenue And Forecasts to 2025, By disease (US$ Mn)
7.4 diabetes Market
7.4.1 Overview
7.4.2 North America Diabetes Market Revenue and Forecasts to 2025 (US$ Mn)
7.5 CANCER Market
7.5.1 Overview
7.5.2 North America Cancer Market Revenue and Forecasts to 2025 (US$ Mn)
7.6 AUTOIMMUNE DISORDERS Market
7.6.1 Overview
7.6.2 North America Autoimmune Disorders Market Revenue and Forecasts to 2025 (US$ Mn)
7.7 OBESITY Market
7.7.1 Overview
7.7.2 North America Obesity Market Revenue and Forecasts to 2025 (US$ Mn)
7.8 MENTAL DISORDERS Market
7.8.1 Overview
7.8.2 North America Mental Disorders Market Revenue and Forecasts to 2025 (US$ Mn)
7.9 Others Market
7.9.1 Overview
7.9.2 North America Others Market Revenue and Forecasts to 2025 (US$ Mn)
PART 8. North America human microbiome market Analysis – By application
8.1 Overview
8.2 NORTH AMERICA Human microbiome MARKET, BY application, 2017 & 2025 (%)
8.3 North America Human microbiome market Revenue And Forecasts to 2025, By Application (US$ Mn)
8.4 Diagnostics Market
8.4.1 Overview
8.4.2 North America Diagnostics Market Revenue and Forecasts to 2025 (US$ Mn)
8.5 therapeutics Market
8.5.1 Overview
8.5.2 North America Therapeutics Market Revenue and Forecasts to 2025 (US$ Mn)
PART 9.North America human microbiome market Revenue and Forecasts to 2025
9.1 Overview
9.2 North America human microbiome market Revenue and Forecasts to 2025 (US$ Mn)
9.3 North America Human microbiome market Revenue And Forecasts to 2025, By Product (US$ Mn)
9.4 North America Human microbiome market Revenue And Forecasts to 2025, By disease (US$ Mn)
9.5 North America Human microbiome market Revenue And Forecasts to 2025, By Application (US$ Mn)
9.6 North America Human microbiome market Revenue And Forecasts to 2025, By Country (%)
9.7 US Human microbiome market Revenue and Forecasts to 2025 (US$ Mn)
9.7.1 US Human Microbiome Market Revenue and Forecasts to 2025 (US$ Mn)
9.7.2 US Human Microbiome Market Revenue And Forecasts to 2025, By Product (US$ Mn)
9.7.3 US Human Microbiome Market Revenue And Forecasts to 2025, By Disease (US$ Mn)
9.7.4 US Human Microbiome Market Revenue And Forecasts to 2025, By Application (US$ Mn)
9.8 Canada Human microbiome market Revenue and Forecasts to 2025 (US$ Mn)
9.8.1 Canada Human Microbiome Market Revenue and Forecasts to 2025 (US$ Mn)
9.8.2 Canada Human Microbiome Market Revenue And Forecasts to 2025, By Product (US$ Mn)
9.8.3 Canada Human Microbiome Market Revenue And Forecasts to 2025, By Disease (US$ Mn)
9.8.4 Canada Human Microbiome Market Revenue And Forecasts to 2025, By Application (US$ Mn)
9.9 Mexico Human microbiome market Revenue and Forecasts to 2025 (US$ Mn)
9.9.1 Mexico Human microbiome Market Revenue and Forecasts to 2025 (US$ Mn)
9.9.2 Mexico Human Microbiome Market Revenue And Forecasts to 2025, By Product (US$ Mn)
9.9.3 Mexico Human Microbiome Market Revenue And Forecasts to 2025, By Disease (US$ Mn)
9.9.4 Mexico Human Microbiome Market Revenue And Forecasts to 2025, By Application (US$ Mn)
PART 10. Human Microbiome Market –Industry Landscape
10.1 Overview
10.2 Growth Strategies in the Human Microbiome Market, 2015-2018
10.3 Organic Growth Strategies
10.3.1 Overview
10.3.2 Product Launch & Approvals
10.3.3 Expansion
10.3.4 Patent and license
10.4 Inorganic Growth Strategies
10.4.1 Overview
10.4.2 Acquisitions
10.4.3 Partnerships, Collaborations & Agreements
10.4.4 Joint Ventures
PART 11. Human microbiome Market–Key company profiles
11.1 ENTEROME
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Financial Overview
11.1.4 Product Portfolio
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 MICROBIOME THERAPEUTICS, LLC
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Financial Information
11.2.4 Product Portfolio
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Rebiotix Inc.
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Financial Overview
11.3.4 Product Portfolio
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Yakult Honsha Co., Ltd.
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Financial Overview
11.4.4 Product Portfolio
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Osel Inc.
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Financial Overview
11.5.4 Product Portfolio
11.5.5 Swot Analysis
11.5.6 Key Developments
11.6 Vedanta Biosciences, Inc.
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Financial Information
11.6.4 Product Portfolio
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Metabiomics Corporate
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Financial Overview
11.7.4 Product Portfolio
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Synthetic Biologics, Inc.
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Financial Information
11.8.4 Product Portfolio
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 DuPont
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Financial Overview
11.9.4 Product Portfolio
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 BiomX
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Financial Information
11.10.4 Product Portfolio
11.10.5 SWOT Analysis
11.10.6 Key Developments
PART 12. Appendix
12.1 About The Insight Partners
12.2 Glossary of Terms
12.3 Methodology
12.3.1 Coverage
12.3.2 Secondary Research
12.3.3 Primary Research
LIST OF TABLES
TABLE 1. North America Human microbiome market Revenue And Forecasts to 2025, By product (US$ Mn)
TABLE 2. North AmericaHuman microbiome market Revenue And Forecasts to 2025, By disease (US$ Mn)
TABLE 3. North America Human microbiome market Revenue And Forecasts to 2025, By application (US$ Mn)
TABLE 4. North America Human microbiome market Revenue And Forecasts to 2025, By product (US$ Mn)
TABLE 5. North AmericaHuman microbiome market Revenue And Forecasts to 2025, By disease (US$ Mn)
TABLE 6. North America Human microbiome market Revenue And Forecasts to 2025, By application (US$ Mn)
TABLE 7. US Human microbiome market Revenue And Forecasts to 2025, By Product (US$ Mn)
TABLE 8. US Human microbiome market Revenue And Forecasts to 2025, By disease (US$ Mn)
TABLE 9. US Human microbiome market Revenue And Forecasts to 2025, By application (US$ Mn)
TABLE 10. Canada Human microbiome market Revenue And Forecasts to 2025, By Product (US$ Mn)
TABLE 11. Canada Human microbiome market Revenue And Forecasts to 2025, By disease (US$ Mn)
TABLE 12. Canada Human microbiome market Revenue And Forecasts to 2025, By application (US$ Mn)
TABLE 13. Mexico Human microbiome market Revenue And Forecasts to 2025, By Product (US$ Mn)
TABLE 14. Mexico Human microbiome market Revenue And Forecasts to 2025, By disease (US$ Mn)
TABLE 15. Mexico Human microbiome market Revenue And Forecasts to 2025, By application (US$ Mn)
TABLE 16. Recent Product Launches & Approvals in the Human Microbiome Market
TABLE 17. Recent EXPANSIONS in the Human Microbiome Market
TABLE 18. Patent and License Organic Growth Strategies in the Human Microbiome Market
TABLE 19. Recent Acquisitions in the Human Microbiome market
TABLE 20. Recent Partnerships & Collaborations in the Human Microbiome market
TABLE 21. Joint Ventures inOrganic Growth Strategies in the Human Microbiome Market
TABLE 22. Glossary of Terms, Human microbiome market
LIST OF FIGURES
FIGURE 1. US Human microbiome market, Revenue (US$ Mn), By countries 2018 & 2025
FIGURE 2. north America human microbiome Market By product, Market Share (%), 2017
FIGURE 3. north America Human microbiome Market By disease, Market Share (%), 2017
FIGURE 4. North America Human microbiome Market By application, Market Share (%), 2017
FIGURE 5. Human microbiome market Segmentation
FIGURE 6. Human microbiome Segmentation, by region
FIGURE 7. North America PEST Analysis
FIGURE 8. human microbiome market impact analysis of drivers & Restraints
FIGURE 9. North America Human microbiome market – Revenue Forecasts and Analysis – 2017- 2025
FIGURE 10. North America Human microbiome market, By Product, 2017 & 2025 (%)
FIGURE 11. North America foods Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 12. North America Medical Food Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 13. North America Probiotics Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 14. North America Prebiotics Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 15. North America drugs Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 16. North America DIAGNOSTIC DEVICES Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 17. North America SUPPLEMENTS Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 18. North America Human microbiome market By disease, 2017 & 2025 (%)
FIGURE 19. North America Diabetes Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 20. North America Cancer Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 21. North America Autoimmune Diseases Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 22. North America Obesity Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 23. North America MENTAL DISORDERS Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 24. North America Others Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 25. North America Human microbiome market By application, 2017 & 2025 (%)
FIGURE 26. North America diagnostics Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 27. North America Therapeutics Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 28. North America human microbiome market REVENUE overview, by Country, 2017 (US$ MN)
FIGURE 29. North America human microbiome Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 30. North America Human microbiome market Revenue And Forecasts to 2025, By Country (%)
FIGURE 31. US Human microbiome market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 32. Canada Human microbiome market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 33. Mexico Human microbiome market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 34. Growth Strategies in the Human Microbiome Market, 2015-2018
FIGURE 35. Organic Growth Strategies in the Human Microbiome Market, 2015-2018
FIGURE 36. Inorganic Growth Strategies in the Endoscopy Device Market, 2015-2018
The List of Companies
- Enterome
- MicroBiome Therapeutics, LLC
- Rebiotix Inc.
- Yakult Honsha Co., Ltd.
- Osel Inc.
- Vedanta Biosciences, Inc.
- Metabiomics Corporate
- Synthetic Biologics, Inc.
- DuPont
- BiomX Ltd.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Feb 2019
Infectious Disease In vitro Diagnostics Market
Size and Forecast (2021-2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Application (HIV or AIDS, Tuberculosis, Hepatitis B and C, Malaria, and Others), End User (Hospitals and Clinics, Diagnostic Laboratories, Blood Bank, and Others), and Geography
Feb 2019
Donor Blood Components Market
Size and Forecast (2021–2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Blood Component (Red Blood Cells, White Blood Cells, Platelets, Plasma, and Others), Indication (Immunosuppression and Oncology), Application (Anemia Management, Thrombocytopenia Treatment, Coagulopathy Correction, Supportive Care During Chemotherapy, Surgery, and Others), Age Group (Adult and Child), End User (Hospitals, Oncology Centers, Transplant Centers, Ambulatory Surgical Centers, and Others), and Geography
Feb 2019
Aesthetic Injectable Devices Market
Size and Forecast (2021-2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Product (Dermal Filler, Botulinum Toxin and Others), Dermal Fillers (Calcium Hydroxylapatite, Hyaluronic Acid, Collagen, Poly-L-Lactic Acid, Polymethylmethacrylate, Fat Fillers, and Others), Device Type (Microcannulas, Pre-Filled Syringes, Mesotherapy Guns, and Others), Application (Facial Line Correction, Face Lift, Lip Treatment, Anti-Ageing and Wrinkle Treatment, Acne and Scar Treatment, Stretch Marks, and Others), Age Group (Up to 30, 31-40, 41-50, 51-60, and More Than 60), Gender (Female and Male), End User (Medical Spas, Dermatology Clinics, Hospitals, and Others), and Geography
Feb 2019
ECG Monitoring Equipment Market
Size and Forecast (2021-2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Resting ECG, Stress ECG, Holter Monitors, and Cardiopulmonary Stress Testing Monitors), Lead Type (12-Lead ECG, 3–6 Lead ECG, and Single Lead), Technology [Portable (Wired) ECG System and Wireless ECG System], End User (Hospital and Clinics, Ambulatory Surgical Centers, Cardiac Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2019
Prescription Drugs Market
Size and Forecast (2021-2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Product Type (Branded and Generics), Drug Type (Small Molecule and Biologics and Biosimilar), Therapeutic Area (Oncology, Cardiovascular Diseases, Neurological Diseases, Metabolic Diseases, Respiratory Diseases, Immunology, and Others), Route Of Administration (Oral, Injectable, Topical, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2019
Regenerative Dentistry Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Natural and Synthetic), Technology (Tissue Engineering, Stem Cell Therapy, and Others), Application (Periodontal Regeneration, Endodontic Regeneration, Tooth Reconstruction, Bone Regeneration, and Others), Age Group (Adult and Pediatric), End User (Dental Clinics, Hospital, and Others), and Geography
Feb 2019
Wound Closure Devices Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Sutures, Adhesives, Staplers, Strips, and Others), Wound Type (Chronic Wound and Acute Wound), End User (Hospitals, Clinics, Ambulatory Surgery Centers, and Others), and Geography
Feb 2019
Cell and Gene Therapy Contract Development and Manufacturing Organization Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Service Type (Drug Development and Manufacturing, Testing and Regulatory Services, and Others), Product Type (Gene Therapy and Cell Therapy), End User (Pharmaceutical Companies, Biopharmaceutical Companies, and Others), and Geography
Get Free Sample For